ENVOY MEDICAL INC (COCH) Fundamental Analysis & Valuation

NASDAQ:COCH • US29415V1098

Current stock price

0.6654 USD
+0.03 (+4.62%)
Last:

This COCH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. COCH Profitability Analysis

1.1 Basic Checks

  • COCH had negative earnings in the past year.
  • COCH had a negative operating cash flow in the past year.
  • COCH had negative earnings in 4 of the past 5 years.
  • COCH had a negative operating cash flow in each of the past 5 years.
COCH Yearly Net Income VS EBIT VS OCF VS FCFCOCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • COCH has a worse Return On Assets (-334.91%) than 93.62% of its industry peers.
Industry RankSector Rank
ROA -334.91%
ROE N/A
ROIC N/A
ROA(3y)-318.48%
ROA(5y)-190.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COCH Yearly ROA, ROE, ROICCOCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 1K -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for COCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COCH Yearly Profit, Operating, Gross MarginsCOCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. COCH Health Analysis

2.1 Basic Checks

  • COCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • COCH has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for COCH has been reduced compared to 5 years ago.
  • There is no outstanding debt for COCH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COCH Yearly Shares OutstandingCOCH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
COCH Yearly Total Debt VS Total AssetsCOCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • COCH has an Altman-Z score of -59.15. This is a bad value and indicates that COCH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of COCH (-59.15) is worse than 95.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -59.15
ROIC/WACCN/A
WACC7.6%
COCH Yearly LT Debt VS Equity VS FCFCOCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that COCH may have some problems paying its short term obligations.
  • COCH's Current ratio of 0.54 is on the low side compared to the rest of the industry. COCH is outperformed by 93.09% of its industry peers.
  • COCH has a Quick Ratio of 0.54. This is a bad value and indicates that COCH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • COCH has a Quick ratio of 0.41. This is amonst the worse of the industry: COCH underperforms 92.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.41
COCH Yearly Current Assets VS Current LiabilitesCOCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. COCH Growth Analysis

3.1 Past

  • COCH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.38%, which is quite good.
  • Looking at the last year, COCH shows a small growth in Revenue. The Revenue has grown by 7.11% in the last year.
EPS 1Y (TTM)17.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.19%
Revenue 1Y (TTM)7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%78.57%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y73.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COCH Yearly Revenue VS EstimatesCOCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 100K 200K 300K
COCH Yearly EPS VS EstimatesCOCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. COCH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COCH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COCH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COCH Price Earnings VS Forward Price EarningsCOCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COCH Per share dataCOCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COCH Dividend Analysis

5.1 Amount

  • No dividends for COCH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COCH Fundamentals: All Metrics, Ratios and Statistics

ENVOY MEDICAL INC

NASDAQ:COCH (4/14/2026, 8:00:01 PM)

0.6654

+0.03 (+4.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23
Earnings (Next)04-29
Inst Owners2.28%
Inst Owner Change0.79%
Ins Owners38.55%
Ins Owner Change85.69%
Market Cap51.16M
Revenue(TTM)241.00K
Net Income(TTM)-28.66M
Analysts82.86
Price Target6.12 (819.75%)
Short Float %2.48%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-6.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-41.18%
Max Revenue beat(2)33.69%
Revenue beat(4)2
Avg Revenue beat(4)-5.55%
Min Revenue beat(4)-41.18%
Max Revenue beat(4)33.69%
Revenue beat(8)2
Avg Revenue beat(8)-21.03%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-36.84%
PT rev (3m)-27.27%
EPS NQ rev (1m)53.33%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)74.58%
EPS NY rev (3m)74.58%
Revenue NQ rev (1m)20%
Revenue NQ rev (3m)20%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 212.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS-0.16
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -334.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-318.48%
ROA(5y)-190.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.27%
Cap/Sales 74.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.41
Altman-Z -59.15
F-Score3
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)246.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)186.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.19%
EPS Next Y73.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%78.57%
Revenue Next Year20%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.41%
OCF growth 3YN/A
OCF growth 5YN/A

ENVOY MEDICAL INC / COCH Fundamental Analysis FAQ

What is the fundamental rating for COCH stock?

ChartMill assigns a fundamental rating of 1 / 10 to COCH.


What is the valuation status for COCH stock?

ChartMill assigns a valuation rating of 0 / 10 to ENVOY MEDICAL INC (COCH). This can be considered as Overvalued.


Can you provide the profitability details for ENVOY MEDICAL INC?

ENVOY MEDICAL INC (COCH) has a profitability rating of 0 / 10.


How financially healthy is ENVOY MEDICAL INC?

The financial health rating of ENVOY MEDICAL INC (COCH) is 1 / 10.


Can you provide the dividend sustainability for COCH stock?

The dividend rating of ENVOY MEDICAL INC (COCH) is 0 / 10 and the dividend payout ratio is -6.35%.